CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc., a personalized cancer diagnostics company that aims to bring comprehensive cancer genome analysis to routine clinical care, today announced that the company will be presenting new methods and data highlighting its progress in optimizing cancer genome analysis using next-generation sequencing (NGS) in routinely-collected patient tissues at the RECOMB 2011 Satellite Workshop on Computational Cancer Biology being held March 26-27, 2011 in Vancouver, B.C.
